Press release - 13/10/2010 GATC Biotech to be First European Service Provider for the PacBio RS GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-to-be-first-european-service-provider-for-the-pacbio-rs
Article - 04/10/2010 Dr. Kerstin Stemmer: important approaches for the early identification of carcinogenic substances Dr. Kerstin Stemmer from the University of Konstanz has found a way to identify the carcinogenic potential of substances in just a few days using state-of-the-art technology and new investigation methods. This is the first time that researchers have been able to reduce the time and the number of animals used in carcinogenesis studies.https://www.gesundheitsindustrie-bw.de/en/article/news/dr-kerstin-stemmer-important-approaches-for-the-early-identification-of-carcinogenic-substances
Press release - 21/09/2010 The National Cohort study The objective of the National Cohort study, the largest prospective study ever conducted in Germany, is to provide answers to a broad range of epidemiological questions, to identify risk factors for common diseases and to open up new treatment pathways. This project is being planned since beginning 2009 by the health centers of the Helmholtz Association in a network with partners from universities and other public research institutions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-national-cohort-study
Article - 20/09/2010 BioFluidix GmbH – the smallest droplets for research and industry The experts at Freiburg-based BioFluidix GmbH specialise in what is known as microfluidics. The company offers solutions for the non-contact dispensing of liquids in the range of a few nanolitres up to several microlitres. These microfluidic devices are used for lab-on-the-chip applications that integrate one or several laboratory steps on a single chip. BioFluidix GmbH a spin-off of the University of Freiburg and member of the MicroTEC Südwest…https://www.gesundheitsindustrie-bw.de/en/article/news/biofluidix-gmbh-the-smallest-droplets-for-research-and-industry
Dossier - 20/09/2010 Neurodegenerative diseases It is estimated that around 1.2 million people in Germany suffer from dementia, and around 200,000 people are diagnosed with neurodegenerative diseases every year. It is expected that by 2050, one in three people in Germany will be over 60 and the number of age-related diseases, particularly dementias, for which no effective curative therapy is currently available, will increase considerably. Given the large numbers of elderly people and…https://www.gesundheitsindustrie-bw.de/en/article/dossier/neurodegenerative-diseases
Article - 13/09/2010 Sven Perner: a pathologist with the courage to carry out interdisciplinary research Dr Sven Perner from Tuebingen was recently awarded the newly created Württemberg Cancer Prize for his work that has made decisive contributions to the understanding of prostate cancer development. In addition the identification of a tumour-specific gene fusion might also be of great importance for other types of cancer. https://www.gesundheitsindustrie-bw.de/en/article/news/sven-perner-a-pathologist-with-the-courage-to-carry-out-interdisciplinary-research
Article - 30/08/2010 Diagnostics for the early detection of cervical cancer The Pap test is regarded as the most successful test for cancer ever, and has saved the lives of many women. However, the test is associated with several weaknesses. The Heidelberg-based in vitro diagnostics company mtm laboratories AG develops and commercialises highly sensitive and highly specific immunochemical tests that provide greater reliability. These tests have the potential to revolutionise the early detection of cervical cancer.https://www.gesundheitsindustrie-bw.de/en/article/news/diagnostics-for-the-early-detection-of-cervical-cancer
Article - 30/08/2010 Genetic testing for the prevention of diseases? Genetic testing is beginning to play an important role in personalised medicine and is indispensable for the diagnosis and therapy of many diseases. However, the preventive and diagnostic power of many genetic tests is still inferior to traditional diagnostic tests. In addition, commercial genetic tests do not always live up to the claims made about them. https://www.gesundheitsindustrie-bw.de/en/article/news/genetic-testing-for-the-prevention-of-diseases
Article - 30/08/2010 A centre focusing on hepatocellular carcinoma research Under its director, Prof. Dr. Peter Schirmacher, the Institute of Pathology at the University of Heidelberg has become a major liver cancer research centre, with a particular focus on hepatocellular carcinoma. The institute is looking for new diagnostic markers and new molecular targets for drugs that have the potential to be used for specifically treating this cancer. https://www.gesundheitsindustrie-bw.de/en/article/news/a-centre-focusing-on-hepatocellular-carcinoma-research
Article - 30/08/2010 More effective prevention and treatment of diabetic feet Dr. med. dent. Hans-Helmut Schmidt has developed a device that enables the effective and hygienic treatment of patients with diabetic foot syndrome DFS. The new device known as DIAPEDES enables diabetic feet to be treated in a closed foot-shaped container under definite clinical conditions. Diabetic feet can smell and look quite unpleasant and the preventive care that this device will offer for many users has been developed with this problem in…https://www.gesundheitsindustrie-bw.de/en/article/news/more-effective-prevention-and-treatment-of-diabetic-feet
Dossier - 30/08/2010 Disease prevention through better diagnostics “Classical treatment approaches are not the only way to ensure good health, rehabilitation and care. In fact, it is envisaged that more effective prevention will contribute to halting the development of diseases and maintaining good health. Prevention is designed to prevent health risks and diseases, make them less likely and delay their onset.” (Declaration of the German government; Official Records of Parliament 17/845, 26th February 2010) https://www.gesundheitsindustrie-bw.de/en/article/dossier/disease-prevention-through-better-diagnostics
Article - 30/08/2010 Bodensee Brustzentrum offers effective breast cancer prevention services The two Brustzentrum Bodensee (Lake Constance Breast Centre) sites at the Hospital in Constance and the Women’s Hospital in Friedrichshafen have a principal goal: to enable the best possible early detection of all types of breast cancer, to reduce the morbidity and mortality of breast cancer patients and to increase survival rates by offering ultra-modern breast cancer prevention measures. https://www.gesundheitsindustrie-bw.de/en/article/news/bodensee-brustzentrum-offers-effective-breast-cancer-prevention-services
Article - 09/08/2010 Quick and early detection of rare diseases Lysosomal storage diseases LSD are a group of around 50 rare inherited metabolic disorders. Only 12 LSDs have been described biochemically and microbiologically. Prof. Dr. Michael Przybylski from the Steinbeis Transfer Centre for Biopolymer Analysis and Proteomics at the University of Constance now hopes to change this situation. In a project carried out in cooperation with the biotech company Genzyme CEE Konstanz and the University of Timisoara…https://www.gesundheitsindustrie-bw.de/en/article/news/quick-and-early-detection-of-rare-diseases
Press release - 05/07/2010 AnDiaTec - Real cowboys have heard of Kornwestheim AnDiaTec GmbH & Co. KG from Kornwestheim is in high demand worldwide as a partner specialising in detection methods for bacteria and viruses. The company is a world market leader in real time PCR Kits for the detection of noroviruses. The U.S. Ministry of Agriculture even draws on the expertise of AnDiaTec in relation to virus infections in cattle. After an intensive period of research and development, the company is now expanding its sales…https://www.gesundheitsindustrie-bw.de/en/article/press-release/andiatec-real-cowboys-have-heard-of-kornwestheim
Article - 28/06/2010 ATG:biosynthetics GmbH – Modular molecular systems of the future ATGbiosynthetics GmbH based in Merzhausen close to Freiburg produces biological systems that can combine gene constituents following a construction kit principle. The company provides the pharmaceutical industry and basic researchers with products that have specifically chosen properties.https://www.gesundheitsindustrie-bw.de/en/article/news/atg-biosynthetics-gmbh-modular-molecular-systems-of-the-future
Press release - 24/06/2010 febit Announces Operational Restructuring febit today announced a restructuring as a consequence of its strategic focus on blood-based microRNA biomarker discovery febits major business development in 20092010 and on partnerships and intellectual property IP commercialization. The new focus includes the collaboration and provision of high-end services for clinical researchers in academia diagnostic companies and the pharma industry. The operational restructuring resulted in a reduction…https://www.gesundheitsindustrie-bw.de/en/article/press-release/febit-announces-operational-restructuring
Article - 07/06/2010 Biametrics – specialist in label-free bioanalysis Biametrics is a spin-off from the University of Tübingen that focuses on the commercialisation of innovative developments in the field of label-free bioanalyses. The companys platform detects interactions between biomolecules using reflectometric interference spectroscopy RIfS and can be integrated into small mobile analytical devices.https://www.gesundheitsindustrie-bw.de/en/article/news/biametrics-specialist-in-label-free-bioanalysis
Press release - 07/06/2010 Addition of renowned experts to Medical Advisory Board and achievement of international quality standards generate added optimism With a € 1.5 Mio Second Closing, Curetis has now increased its Series A financing round to € 20 Mio. This additional financing will enable Curetis to complete the development of its innovative diagnostic products through to market entry. Quality Certification for its diagnostic product development represents an additional milestone in Curetis' commercial strategy. At the same time, Curetis has added internationally recognized expertise in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/addition-of-renowned-experts-to-medical-advisory-board-and-achievement-of-international-quality-stan
Press release - 21/05/2010 The fingerprints of molecules Prof. Heiko Möller is head of the NMR Core Facility a centre at the University of Constance that focuses on magnetic resonance spectroscopy where fingerprints of molecules are taken. The highly sensitive analysis instruments are used by his group of researchers for research projects on subjects ranging from severed visual nerves cancer protection and the rapid identification of anthrax bacteria.https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-fingerprints-of-molecules
Article - 10/05/2010 CeGaT: DNA and RNA sequencing specialist Sequencing service providers are facing new challenges due to the enormous technological progress made in this field. The market requires technically feasible solutions reliable and rapid sequence analyses in which entire genomes can be analysed within a couple of days or weeks. This can only be achieved with state-of-the-art high-throughput technologies. Tübingen-based CeGaT GmbH has been offering DNA and RNA sequencing using state-of-the-art…https://www.gesundheitsindustrie-bw.de/en/article/news/cegat-dna-and-rna-sequencing-specialist
Article - 07/05/2010 Günter Gauglitz: research at the boundaries of physics, chemistry and biology Biosensors and label-free optical bioanalysis are the major research priorities of Prof. Dr. Günter Gauglitz from the Institute for Physical and Theoretical Chemistry IPC at the University of Tübingen. His whole career has been about the acquisition of multi-million third-party funded projects that are worked on by a team of 15 scientists at the IPC.https://www.gesundheitsindustrie-bw.de/en/article/news/guenter-gauglitz-research-at-the-boundaries-of-physics-chemistry-and-biology
Press release - 06/05/2010 Second Biomarker Expert Meeting in Heidelberg Numerous experts in molecular diagnostics convened at the Second Workshop of the Biomarker Discovery Center (BDC) in Heidelberg. More than 40 researchers from universities, hospitals and industry from various regions of Germany made their way to the city despite adverse travel conditions caused by the volcanic ash cloud.https://www.gesundheitsindustrie-bw.de/en/article/press-release/second-biomarker-expert-meeting-in-heidelberg
Press release - 23/04/2010 International Cancer Genome Project Publishes Article in Nature Information obtained in the various projects of the International Cancer Genome Consortium may soon be used to the benefit of cancer patients worldwide because the data will be freely accessible and not patentable. The project thus aims to make sure that the molecular data of the various tumor types can be used as swiftly as possible for new diagnostic methods or therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-cancer-genome-project-publishes-article-in-nature
Press release - 22/04/2010 Biotechnology is a driver of economic growth The latest economic figures on biotechnology were presented at the German Biotechnology Days held in Berlin on 21st and 22nd April 2010. The figures show that German biotechnology companies have not lost their innovation power despite the global financial crisis. In 2009 the companies RD expenditures of around one billion euros remained at a similar high level to the previous year. The biotechnology industry is creating new jobs despite the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/biotechnology-is-a-driver-of-economic-growth
Article - 19/04/2010 Natural antibodies to treat Alzheimer’s Alzheimers disease is characterised by changes in the substance and structure of the brain that are caused by the depositing of protein plaques in the brain. Prof. Michael Przybylski and his team of researchers at the University of Constance have deciphered the structure of the site where mouse antibodies attach to the plaques subsequently causing them to dissolve. These findings will now be used to identify the binding structure of a component…https://www.gesundheitsindustrie-bw.de/en/article/news/natural-antibodies-to-treat-alzheimer-s